Maternal serum inhibin A concentrations in early pregnancy after IVF and embryo transfer reflect the corpus luteum contribution and pregnancy outcome
- 1 September 2000
- journal article
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 15 (9), 2028-2032
- https://doi.org/10.1093/humrep/15.9.2028
Abstract
To compare maternal serum inhibin A concentrations in early pregnancy with pregnancy outcomes and treatment protocols, serum samples were collected from 237 women undergoing in-vitro fertilization (IVF) and embryo transfer cycles. Samples were collected on day 16 after oocyte retrieval for beta human chorionic gonadotrophin (HCG) pregnancy testing and inhibin A measurement. The samples were divided into non-pregnant (n = 128) and pregnant (n = 109) groups, the pregnancies were followed and outcomes determined. Inhibin A concentrations were significantly lower in non-pregnant women than in women with ongoing pregnancies (P: < 0.001) and those resulting in spontaneous abortions (P: < 0.001). In ongoing pregnancies, inhibin A concentrations were significantly lower in the absence of functioning ovaries (donor oocyte/embryo) (P: < 0.01) and in natural cycles (frozen-thawed embryo transfer) (P: < 0.01) compared with concentrations after ovarian stimulation. Further, since inhibin A concentrations were not significantly different between singleton and multiple pregnancies in the ovarian stimulation protocol, the size of the early trophoblast does not appear to influence the secretion of inhibin A. These data strongly support the concept that the corpus luteum is a major source of circulating inhibin A in early pregnancy. Additionally, low concentrations of serum inhibin A may be useful in predicting betaHCG-positive preclinical 'biochemical' pregnancies.Keywords
This publication has 24 references indexed in Scilit:
- Inhibin A and inhibin B reflect ovarian function in assisted reproduction but are less useful at predicting outcomeHuman Reproduction, 1999
- A longitudinal study of maternal serum inhibin-A, inhibin-B, activin-A, activin-AB, pro-alphaC and follistatin during pregnancyHuman Reproduction, 1998
- Ovarian reserve tests in infertility practice and normal fertile womenMaturitas, 1998
- Follicle stimulating hormone as a predictor of fertilityCurrent Opinion in Obstetrics and Gynecology, 1998
- Measurement of Inhibin and Activin in Early Human Pregnancy: Demonstration of Fetoplacental Origin and Role in Prediction of Early-Pregnancy Outcome1Biology of Reproduction, 1997
- Inhibin A and Activin A in the First Trimester of Human PregnancyJournal of Clinical Endocrinology & Metabolism, 1997
- Detection of dimeric inhibin throughout the human menstrual cycle by two‐site enzyme immunoassayClinical Endocrinology, 1994
- Inhibin Concentrations throughout the Menstrual Cycles of Normal, Infertile, and Older Women Compared with Those during Spontaneous Conception CyclesJournal of Clinical Endocrinology & Metabolism, 1991
- PHARMACOLOGICAL‘RESCUE’OF THE CORPUS LUTEUM RESULTS IN INCREASED INHIBIN PRODUCTIONClinical Endocrinology, 1990
- The Isolation and Physiology of Inhibin and Related ProteinsBiology of Reproduction, 1989